111 results
424B5
VKTX
Viking Therapeutics Inc
1 Mar 24
Prospectus supplement for primary offering
4:13pm
may or may not be listed on a national securities exchange. We can make no assurance as to the liquidity of or the existence of trading markets
8-K
EX-1.1
x4fre3f3614zuq
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
424B5
y0fqfwke
27 Feb 24
Prospectus supplement for primary offering
5:21pm
S-3ASR
6sixi3l
26 Jul 23
Automatic shelf registration
5:26pm
8-K
EX-3.1
5x1m 9bg5
11 May 23
Amendments to Articles of Incorporation or Bylaws
5:00pm